Benzodiazepine receptor and serotonin 2A receptor modulate the aversive-like effects of nitric oxide in the dorsolateral periaqueductal gray of rats

Autor(es)

Moreira‚ F. A. ; Guimarães‚ F. S.

• Tipo de documento: Artigo Científico
• Fonte: Psychopharmacology; v. 176, n. 3/4, p. 362-368, Nov. 2004.
• Área do conhecimento: Ciências Biológicas - Farmacologia
• Assunto(s): Inibidores enzimáticos Óxido nítrico Receptores de benzodiazepina Receptores de serotonina

Resumo

Rationale - Escape reactions induced by electrical stimulation of the dorsolateral periaqueductal gray (dlPAG) are inhibited by local administration of benzodiazepine (BZ) or serotonin (5-HT) receptor agonists. Nitric oxide (NO) is a gas messenger that may mediate aversive behaviors. NO donors injected into the dlPAG induce escape reactions. Objectives - To test the hypothesis that the escape reactions induced by a NO donor in the dlPAG would be attenuated by pre-treatment with BZ-receptor or 5-HT-receptor agonists. Methods - Male Wistar rats with cannulae aimed at the dlPAG received microinjections of vehicle (0.2 μl), the BZ midazolam maleate (80 nmol), the 5-HT1A-receptor agonist 8-OH-DPAT (8 nmol or 16 nmol) or the 5-HT2A/2C-receptor agonist DOI (16 nmol) 10 min before the administration of the NO donor SIN-1 (150 nmol). Behavioral observation took place immediately after the last injection in an open arena over a 10-min period. Results - SIN-1 induced escape reactions characterized by running and jumps. Pre-treatment with DOI, but not 8-OH-DPAT, partially inhibited the effects of SIN-1. Pre-treatment with midazolam maleate, however, completely prevented the effects of the NO donor. Conclusion - The results suggest that the aversive-like effects of NO donor in the dlPAG may be modulated by the BZ and 5-HT2A/2C receptors. (AU)

• Processo FAPESP: 02/13197-2 - Participação do glutamato e óxido nítrico na fisiopatogenia de distúrbios neuropsiquiátricos
• Beneficiário: Francisco Silveira Guimaraes
• Linha de fomento: Auxílio à Pesquisa - Temático
• Processo FAPESP: 02/05406-0 - Efeitos do tratamento cronico com clomipramina na mediacao de respostas aversivas pelo oxido nitrico.
• Beneficiário: Fabricio de Araujo Moreira
• Linha de fomento: Bolsas no Brasil - Doutorado